BiotechTube
Home/Chemestmed/Simona Selberg, Ph.D.
SS

Simona Selberg, Ph.D.

Head of Research and Development

Chemestmed

Therapeutic Areas

CNS DisordersMetabolic DiseasesOncology

Chemestmed Pipeline

DrugIndicationPhase
METTL3/METTL14 ActivatorsAnxiety, Parkinson's Disease, Type 2 Diabetes, ObesityPreclinical
METTL16/ALKBH5/FTO/Reader InhibitorsOncology, Neurodegenerative DiseasesPreclinical

Leadership Team at Chemestmed

NS
Neinar Seli, Ph.D.
Founder and CEO
SS
Sigrid Selberg, Ph.D.
Chief Scientific Officer
EA
Erik Allikmets, M.D.
Chief Medical Officer
View full Chemestmed profile